CD8A and neoplasm: We observed a significant increase in the frequency of PD1+CD8+ T cells in tumors of mice bearing the Arf1‐ablated tumor cells, whereas the increase was completely abolished after treatment with both anti‐IFNAR1 and anti‐IL‐1β antibodies (Figure S12a, Supporting Information).